Income Taxes (Details) - USD ($) |
3 Months Ended | 12 Months Ended | |
|---|---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
Dec. 31, 2024 |
|
| Income Taxes [Line Items] | |||
| Deferred tax asset | $ 77,500,000 | ||
| Tax benefit | 69,400,000 | ||
| Valuation allowance | 77,500,000 | ||
| Net of valuation allowance | $ 0 | ||
| Financial largest benefit | 50.00% | ||
| Minimum [Member] | |||
| Income Taxes [Line Items] | |||
| Amount of federal NOLs | 1,000,000 | ||
| Federal rate | 73,000,000 | ||
| Amount of state NOLs | 49,000,000 | ||
| Federal research and development | 0 | ||
| Maximum [Member] | |||
| Income Taxes [Line Items] | |||
| Amount of federal NOLs | 15,000,000 | ||
| Federal rate | 59,000,000 | ||
| Amount of state NOLs | 93,000,000 | ||
| Federal research and development | 752,000 | ||
| Israel [Member] | Minimum [Member] | |||
| Income Taxes [Line Items] | |||
| Israeli NOL’s | 134,000,000 | ||
| Israel [Member] | Maximum [Member] | |||
| Income Taxes [Line Items] | |||
| Israeli NOL’s | $ 127,000,000 | ||
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of deferred tax liability attributable to taxable temporary differences from research and development costs. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Percentage of plan assets to benefit obligation of defined benefit plan. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|